Skip to main content
Skip to main content
CBSTF logo

The Cannabist Company Holdings Inc. (CBSTF) Stock Analysis

Educational signal · not a buy or sell recommendation · How to read this

DELISTED

What happened to The Cannabist Company Holdings Inc. (CBSTF) stock?

The Cannabist Company Holdings Inc. (CBSTF) no longer trades on public markets. The figures below are historical and are not a current quote.

52-wk range: $0.02 – $0.16

Beta 0.75: the stock has moved about 25% less than the S&P 500.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

The Cannabist Company Holdings Inc. (CBSTF). The Cannabist Company Holdings Inc. cultivates, manufactures, and provides cannabis products and related services across the United States and internationally. Sector: Healthcare.

Last analyzed: Mar 17, 2026
The Cannabist Company Holdings Inc. cultivates, manufactures, and provides cannabis products and related services across the United States and internationally. They offer a range of cannabis products, holding licenses in 17 jurisdictions within the U.S.
Watch the CBSTF film Every key number, told as a short cinematic story — just press play. ~2 min

These figures come from statements filed 12 months ago — the most recent this company has published.

Council Score · Weighted Average of 3 Disciplines
Split View 53/100 · B

CBSTF: 1/2 scored disciplines lean bearish. Dominant signal: Izzy Englander bullish.

How is this calculated? →
Legends Council · 5 Legends + Moon AI

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated)Ray Dalio
Favorable read
Englander-style lens (simulated)Izzy Englander
Favorable read
Klarman-style lens (simulated)Seth Klarman
Neutral read
Moon AI lens (model)
Neutral read
Munger's Mindset · Balance Sheet & Valuation
Financial Health
Weak
Margin of Safety
Fairly Valued
Council Score · Weighted Average of 3 Disciplines · See tabs for details →
The lenses are modelled on the published principles of the investors named. We are not affiliated with them, they have not endorsed this, and it is not their opinion of this stock.

The Cannabist Company Holdings Inc. (CBSTF) Healthcare & Pipeline Overview

CEODavid J. Hart
Employees2,829
HeadquartersNew York City, US
IPO Year2019

The Cannabist Company Holdings Inc. operates in the cannabis industry, cultivating, manufacturing, and distributing a variety of cannabis products. With licenses in 17 U.S. jurisdictions, the company offers flower, edibles, oils, and tablets under multiple brands, positioning itself in the competitive and evolving cannabis market.

Data Provenance | Financial Data Quantitative Analysis Analysis: Mar 17, 2026

What Is the Investment Thesis for CBSTF?

AI-written as of Mar 17, 2026 — figures and tone reflect the data available then, not today's score.

The Cannabist Company Holdings Inc. presents a speculative investment opportunity within the evolving cannabis industry. The company's multi-state presence, with licenses in 17 jurisdictions, provides a foundation for growth as legalization expands. However, the company's negative P/E ratio of -0.07 and a negative profit margin of -51.2% indicate significant financial challenges. The gross margin of 29.5% suggests potential for improvement through operational efficiencies and strategic pricing. Key catalysts include potential regulatory changes and expansion into new markets. Investors should closely monitor the company's ability to achieve profitability and manage its operational costs. The company's beta of 0.75 suggests lower volatility compared to the overall market.

Based on FMP financials and quantitative analysis

CBSTF Key Highlights

AI-written as of Mar 17, 2026 — figures and tone reflect the data available then, not today's score.

Market capitalization of $0.01 billion indicates a small-cap company with potential for growth but also higher risk.

  • Negative P/E ratio of -0.07 reflects current unprofitability, requiring careful monitoring of future earnings potential.
  • Profit margin of -51.2% highlights significant operational challenges and the need for improved cost management.
  • Gross margin of 29.5% suggests potential for profitability if operational efficiencies are improved.
  • Licenses in 17 U.S. jurisdictions provide a substantial footprint for expansion as cannabis legalization progresses.

Who Are CBSTF's Competitors?

CBSTF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap MoonshotScore
CANSF Atlas Energy Corp. $0.08 -7.66% $27.6M
CNTMF Fluent Corp. $0.02 +4.65% $10.5M
GHBWF Glass House Brands Inc. $0.13 +8.33% $10.7M
MKKGY Merck KGaA $30.59 +0.33% $66.5B 499-signal
TAK Takeda Pharmaceutical Company Limited $18.11 -0.55% $57.6B 635-pillar
TEVA Teva Pharmaceutical Industries Limited $36.65 +0.84% $42.7B 605-pillar
HLN Haleon plc $9.22 -0.11% $40.6B 775-pillar
SDZNY Sandoz Group AG $81.08 -2.68% $35.1B 519-signal

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.

What Are CBSTF's Key Strengths?

Licenses in 17 U.S. jurisdictions.

  • Diverse product portfolio.
  • Established brand names.
  • Vertical integration.

What Are CBSTF's Weaknesses?

Negative profit margin.

  • High operational costs.
  • Limited brand recognition compared to larger competitors.
  • Dependence on regulatory changes.

What Could Drive CBSTF Stock Higher?

Expansion into new markets as cannabis legalization progresses.

  • Product innovation and diversification to meet evolving consumer preferences.
  • Potential regulatory changes at the state or federal level.
  • Strategic partnerships and acquisitions to expand market reach.
  • Efforts to improve operational efficiency and reduce costs.

What Are the Key Risks for CBSTF?

Financial-distress signal — its Altman Z-Score of -3.31 sits in the distress zone (elevated bankruptcy risk).

  • Inconsistent delivery — missed Wall Street EPS estimates in 6 of the last 8 reported quarters.
  • Weak fundamentals — a Piotroski F-Score of 1/9 flags soft profitability, leverage or efficiency.
  • Intense competition from other cannabis companies.
  • Regulatory uncertainty and changing laws.
  • Fluctuations in cannabis prices.
  • Negative public perception of cannabis.
  • Limited access to capital due to the nature of the business.

What Are the Growth Opportunities for CBSTF?

  • Expansion into New Markets: As cannabis legalization continues to spread across the United States and internationally, The Cannabist Company has the opportunity to expand its operations into new markets. Each new state or country that legalizes cannabis represents a potential revenue stream and growth opportunity. The timeline for this growth is dependent on the pace of legalization efforts, but the long-term trend is toward greater acceptance and accessibility. The company's existing licenses in 17 U.S. jurisdictions provide a strong foundation for further expansion.
  • Product Innovation and Diversification: The Cannabist Company can drive growth by innovating and diversifying its product offerings. This includes developing new cannabis-infused products, exploring different consumption methods, and catering to specific consumer preferences. The market for cannabis-infused beverages, edibles, and wellness products is growing rapidly, presenting opportunities for the company to capture new market segments. The timeline for product development and launch is relatively short, allowing the company to quickly adapt to changing consumer demands.
  • Strategic Partnerships and Acquisitions: The Cannabist Company can accelerate its growth through strategic partnerships and acquisitions. Collaborating with other companies in the cannabis industry, such as technology providers, distribution networks, or retail operators, can enhance its operational capabilities and market reach. Acquiring smaller companies with complementary products or technologies can also drive growth and expand its market share. The timeline for partnerships and acquisitions varies depending on the specific opportunities, but these strategies can provide significant growth potential in the medium to long term.
  • Brand Building and Marketing: Investing in brand building and marketing is crucial for The Cannabist Company to differentiate itself from competitors and attract new customers. Developing strong brand recognition and loyalty can drive sales and increase market share. This includes creating compelling marketing campaigns, engaging with consumers through social media, and sponsoring events. The timeline for brand building is ongoing, requiring consistent effort and investment over the long term. A strong brand can command premium pricing and create a sustainable competitive advantage.
  • Operational Efficiency and Cost Optimization: Improving operational efficiency and optimizing costs can significantly enhance The Cannabist Company's profitability and competitiveness. This includes streamlining its cultivation and manufacturing processes, reducing waste, and optimizing its supply chain. Implementing technology solutions, such as automation and data analytics, can also drive efficiency and reduce costs. The timeline for operational improvements is ongoing, requiring continuous monitoring and optimization. Increased efficiency can lead to higher gross margins and improved financial performance.

What Are CBSTF's Competitive Advantages?

  • Licenses: Holding licenses in 17 U.S. jurisdictions creates a barrier to entry.
  • Brand Portfolio: A diverse portfolio of brands caters to different consumer segments.
  • Vertical Integration: Controlling the cultivation, manufacturing, and distribution processes provides greater control over the supply chain and product quality.

What Does CBSTF Do?

The Cannabist Company Holdings Inc., formerly known as Columbia Care Inc., was founded in 2012 and rebranded in September 2023. Headquartered in New York City, the company operates in the cannabis industry, focusing on the cultivation, manufacturing, and distribution of cannabis products and related services. The company's product offerings include flower, edibles, oils, and tablets, marketed under brand names such as Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Press, and Amber. The Cannabist Company holds licenses in 17 jurisdictions within the United States, allowing it to operate across multiple states. This multi-state presence is crucial in the fragmented legal landscape of the cannabis industry in the U.S. The company aims to cater to a broad spectrum of consumer preferences through its diverse product portfolio. By offering a range of consumption methods and product types, The Cannabist Company seeks to capture different segments of the cannabis market. The company's strategic focus includes expanding its brand presence and optimizing its operational efficiency within existing markets. The Cannabist Company navigates the complex regulatory environment of the cannabis industry to establish a strong foothold in key markets.

What Products and Services Does CBSTF Offer?

  • Cultivates cannabis plants in licensed facilities.
  • Manufactures a variety of cannabis products, including flower, edibles, oils, and tablets.
  • Distributes cannabis products through its own retail locations and wholesale channels.
  • Markets its products under various brand names, such as Seed & Strain, Triple Seven, and Hedy.
  • Holds licenses to operate in 17 jurisdictions in the United States.
  • Provides cannabis-related services to consumers and businesses.

How Does CBSTF Make Money?

  • Cultivation and Manufacturing: The company grows cannabis and manufactures various cannabis products.
  • Retail Sales: The company sells its products directly to consumers through its own retail stores.
  • Wholesale Distribution: The company distributes its products to other retailers and dispensaries.

What Industry Does CBSTF Operate In?

The Cannabist Company operates within the rapidly evolving cannabis industry, which is characterized by increasing legalization and market expansion. The U.S. cannabis market is projected to reach significant growth in the coming years, driven by both medical and recreational use. The competitive landscape includes both large multi-state operators and smaller regional players. Companies like CANSF (Columbia Care Cannabis Corp), CNTMF (Cresco Labs Inc.), DXBRF (Dixie Brands Inc.), ELIXF (Elixinol Wellness Limited), and GHBWF (Greenlane Holdings Inc.) represent key competitors, each vying for market share through different strategies, such as brand differentiation, geographic expansion, and product innovation. The industry faces regulatory hurdles and varying state laws, requiring companies to navigate a complex legal environment.

Who Are CBSTF's Key Customers?

  • Adult recreational cannabis users.
  • Patients with medical cannabis prescriptions.
  • Wholesale clients, including other dispensaries and retailers.
Model self-rating on this text: 79% (not a measure of the evidence) Updated: Mar 17, 2026

Research confidence

Low 3/100

Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.

  • Scoring coverage unknown
  • No price timestamp
  • Latest filing 346 days ago
  • No analyst coverage
Net buying

Insider Activity

The most recent 10 insider filings for The Cannabist Company Holdings Inc. break down as 3 sales and 7 purchases. On net that is roughly 4.6M shares acquired (about $70) — insiders putting money in tends to read as conviction.

FY2026 est

Forward Outlook

Wall Street analysts project The Cannabist Company Holdings Inc. revenue of about $336.0M for fiscal 2026, with EPS near $-0.13.

2/8 beats

Earnings Track Record

The Cannabist Company Holdings Inc. has missed Wall Street's EPS estimate in 6 of its last 8 reported quarters — a mixed record worth weighing. Reported results have landed about 195.7% below estimates on average.

F-Score 1/9

Financial Health

The Cannabist Company Holdings Inc.'s Piotroski F-Score is 1/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -3.31 places it in the distress zone, a signal of elevated financial risk.

ROE 107%

Key Financial Metrics

Return on equity for The Cannabist Company Holdings Inc. stands at 106.5%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -23.2%, showing how much profit it generates from its asset base. A current ratio of 0.89 means current liabilities exceed short-term assets, a liquidity point worth watching.

CBSTF Revenue & Earnings Trend

In Q3 FY2025, CBSTF generated $79.9M in top-line revenue, marking a sequential decrease of 7.5%. The company recorded a net loss of $14.3M, with diluted EPS of $-0.03. Revenue has contracted over three consecutive quarters, which investors in this unknown Healthcare stock should monitor closely. Across the four most recent quarters, CBSTF averaged $-0.09 in diluted EPS.

Company Profile

The Cannabist Company Holdings Inc. operates in the REIT - Industrial industry within the Real Estate sector. It is headquartered in Malvern, US. The company is led by CEO Christopher Marr. CBSTF has traded publicly since 2004.

CBSTF Financials

Fundamental Snapshot

Revenue Growth (FY)
-10.3%
Net Income Growth (FY)
+39.7%
EPS Growth (FY)
+47.7%

Based on FMP financials and quantitative analysis · FY 2024

Bull Case vs Bear Case

Bull Case

  • Licenses in 17 U.S. jurisdictions.
  • Diverse product portfolio.
  • Established brand names.
  • Vertical integration.

Bear Case

  • Negative profit margin.
  • High operational costs.
  • Limited brand recognition compared to larger competitors.
  • Dependence on regulatory changes.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026

Recent Quarterly Results

Quarter Revenue Net Income EPS
Q3 FY2025 $80M -$14M -$0.03
Q2 FY2025 $86M -$78M -$0.16
Q1 FY2025 $87M -$32M -$0.07
Q4 FY2024 $96M -$55M -$0.12

Q3 FY2025 · filed 30 Sep 2025 · SEC EDGAR →

Based on FMP financials and quantitative analysis

CBSTF Latest News

Leadership: David J. Hart

Unknown

Information on David J. Without additional data, it is impossible to provide details on his career history, education, or previous roles.

Track Record: Information on David J. Hart's track record is not available in the provided context. Without additional data, it is impossible to provide details on his key achievements, strategic decisions, or company milestones under his leadership.

CBSTF OTC Market Information

The OTC Other tier represents the lowest tier of the OTC market, indicating that The Cannabist Company Holdings Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB, or major exchanges like NYSE or NASDAQ. Companies in this tier often have limited operating history, may be thinly traded, and are subject to less stringent regulatory oversight. This tier is typically associated with higher risk and requires greater due diligence from investors compared to companies listed on major exchanges.

  • OTC Tier: OTC Other
Liquidity: As an OTC stock, CBSTF's liquidity may be limited. Trading volume can be low, leading to wider bid-ask spreads and potentially making it difficult to buy or sell large quantities of shares without significantly impacting the price. Investors should be aware of these liquidity constraints and consider the potential challenges in executing trades efficiently. The limited liquidity can also increase price volatility.
OTC Risk Factors:
  • Limited liquidity due to low trading volume.
  • Less stringent regulatory oversight compared to major exchanges.
  • Higher price volatility.
  • Potential for limited or delayed financial reporting.
  • Increased risk of fraud or manipulation.
Due Diligence Checklist:
  • Verify the company's legal status and registration.
  • Review available financial statements and disclosures.
  • Assess the company's management team and their experience.
  • Research the company's business model and competitive landscape.
  • Evaluate the company's risk factors and potential liabilities.
  • Monitor trading volume and price volatility.
  • Consult with a financial advisor before investing.
Legitimacy Signals:
  • The company has been in operation since 2012.
  • The company holds licenses in 17 U.S. jurisdictions.
  • The company has a diverse product portfolio.
  • The company has a physical headquarters in New York City.

CBSTF Healthcare Stock FAQ

What happened to The Cannabist Company Holdings Inc. (CBSTF) stock?

The Cannabist Company Holdings Inc. (CBSTF) no longer trades on public markets. The figures below are historical and are not a current quote.

Can I still buy CBSTF shares?

No. CBSTF stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for CBSTF elsewhere is historical data, not a live market.

Are the figures on this page current?

No. Every number here is the last value recorded before CBSTF stopped trading. Nothing on this page updates, and none of it is a current quote.

Why does this page still exist?

Because people still search for what happened to The Cannabist Company Holdings Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.

What does The Cannabist Company Holdings Inc. do?

The Cannabist Company Holdings Inc. cultivates, manufactures, and distributes a range of cannabis products, including flower, edibles, oils, and tablets, under various brand names.

What are the main risks for CBSTF?

The Cannabist Company faces several key risks, including intense competition in the cannabis industry, regulatory uncertainty, and fluctuations in cannabis prices.

What revenue streams does The Cannabist Company Holdings Inc. have in healthcare?

The Cannabist Company Holdings Inc. generates revenue through the sale of cannabis products, including flower, edibles, oils, and tablets, to both medical and recreational users. The company's revenue streams are geographically diversified across the 17 U.S. jurisdictions where it holds licenses.

How does The Cannabist Company Holdings Inc. compete with larger cannabis companies?

The Cannabist Company Holdings Inc. competes with larger cannabis companies through a combination of strategic differentiation and operational focus. While lacking the scale and resources of larger multi-state operators, The Cannabist Company leverages its established brand names, diverse product portfolio, and licenses in key markets to carve out a competitive niche.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Information is based on available data and may be subject to change.
  • Financial data may not be fully up-to-date due to the nature of the OTC listing.
Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis

More Stocks We Cover